Sign up
Pharma Capital

UK RNS Announcements

Date Provider Announcement
21/11/2018 LSE:IRSH GEM - Cancellation Notice
21/11/2018 LSE:HHPD Subsidiary obtaining Hongfu Innovation shares.
21/11/2018 XLON:INTU Form 8.5 (EPT/RI)- Intu Properties PLC
21/11/2018 LTS:0RN3 Form 8.5 (EPT/RI)- Takeda Pharmaceutical Co Ltd
21/11/2018 XLON:SHP Form 8.5 (EPT/RI)- Shire plc
21/11/2018 XLON:INTU Form 8.5 (EPT/NON-RI)- Intu Properties PLC
21/11/2018 XLON:BTG Form 8.5 (EPT/RI)- BTG plc
21/11/2018 London Stock Exchange Form 8.5 (EPT/RI)- Sibanye Gold Limited
21/11/2018 XLON:LMI Form 8.5 (EPT/RI)- Lonmin plc
21/11/2018 XLON:JLT Form 8.5 (EPT/RI)-Jardine Lloyd Thompson Group Plc
21/11/2018 LSE:SCPA Director/PDMR Shareholding
21/11/2018 LSE:IRSH MSM - Cancellation Notice
21/11/2018 XLON:KIT Keystone Investment Trust Plc - Net Asset Value(s)
21/11/2018 XLON:IPE Invesco Perpetual Enhanced Income Ltd - Net Asset Value(s)
21/11/2018 XLON:IVPG Invesco Perpetual Select Trust Plc - Net Asset Value(s)
21/11/2018 XLON:IAT Invesco Asia Trust Plc - Net Asset Value(s)
21/11/2018 LSE:BVS Director/PDMR Shareholding
21/11/2018 XLON:IVPB Invesco Perpetual Select Trust Plc - Net Asset Value(s)
21/11/2018 XLON:PLI Perpetual Income & Growth Investment Trust Plc - Net Asset Value(s)
21/11/2018 XLON:IVI Invesco Income Growth Trust Plc - Net Asset Value(s)
21/11/2018 XLON:IVPU Invesco Perpetual Select Trust Plc - Net Asset Value(s)
21/11/2018 XLON:IVPM Invesco Perpetual Select Trust Plc - Net Asset Value(s)
21/11/2018 XLON:CMHY City Merchants High Yield Trust Ltd - Net Asset Value(s)
21/11/2018 XLON:INTU Form 8.5 (EPT/RI)
21/11/2018 XLON:IPU Invesco Perpetual UK Smaller Co's Investment Trust Plc - Net Asset Value(s)

© biotech Capital 2018

Biotech Capital, a subsidiary of Proactive Investors, acts as the vanguard for listed biotech companies to interact with institutional and highly capitalised investors.
Headquartered in London, Biotech Capital is led by a team of Europe's leading analysts and journalists, publishing daily content, covering all key movements in the Biotechnology market.